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About 10 years ago there was a heated debate over 
whether v-Src and several other retrovirally encoded pro- 
tein-tyrosine kinases had lipid kinase activity in addition 
to protein kinase activity. Ultimately, the analysis of the 
unusual lipid kinase activity associated with v-Src led to 
the discovery of a novel type of phosphatidylinositol (PI) 
kinase, the PI 3-kinases. This in turn led to the character- 
ization of a type of PI 3-kinase that associates with phos- 
photyrosine-containing proteins via a regulatory subunit, 
~85, that has two SH2 domains. The catalytic domain of 
this PI 3-kinase, ~110, proved to contain a C-terminal re- 
gion distantly related to the catalytic domain of the protein 
kinase superfamily and containing motifs conserved in 
subdomains VI6 (motif I) and VII (motif II) of the protein 
kinase catalytic domain (Hiles et al., 1992) (Figure 1). ~110 
has PI 3-kinase activity in the absence of ~85, and this 
activity is abolished when Arg-916 in one of the conserved 
protein kinase motifs is mutated to Pro. This shows that 
the PI 3-kinase activity is intrinsic and that the protein 
kinase-like region is required for this activity, although the 
boundaries of the minimal catalytic domain have not been 
precisely defined (Dhand et al., 1994). 
Since that time, a large family of proteins related to the 
catalytic domain of the ~110 PI 3-kinase subunit has been 
uncovered (Table 1). Based on the demonstrable PI kinase 
activities of pl 1 Oa, ~1106, Vps34p, and the PI 4-kinases, 
one might have predicted that all of these proteins would 
have PI kinase activity. Ironically, however, we have now 
come full circle, and it appears that a subset of the PI 
3-kinase family members have protein kinase activity. 
Some PI 3.Kinase Family Members Are Bona Fide 
Lipid Kinases 
pl 1 Oa, ~1108, and pl 1 Oy, Vps34p and its human homo- 
log, and the PI 4-kinases have all been shown to have 
intrinsic PI kinase activity, although they have distinct sub- 
strate specificities; pl lOa, ~1108, and plOOy can phos- 
phorylate the 3’position on the inositol ring of PI and Pl(4)P, 
but preferentially phosphorylate Pl(4,5)P2, whereas the 
yeast and human VPS34 PI 3-kinases and the PI 4-kinases 
can only phosphorylate PI. (Note that the Pl(4)P 5kinases 
form a separate, unrelated family [Boronenkov and Ander- 
son, 19951). In contrast, there is little evidence that other 
members of the family have PI kinase activity. FRAP (Sa- 
batini et al., 1995) and ToRp (Cardenas and Heitman, 
1995) have been shown to possess associated PI 4-kinase 
activity when isolated by immunoprecipitation. In neither 
case, however, is the PI 4-kinase activity inhibited by rapa- 
mycin, even though FRAP and ToRp bind rapamycinl 
FKBP and have been identified as targets for inhibition 
by rapamycin, a macrolide that inhibits the growth of many 
cells. When a temperature-sensitive mutant of ToRp was 
examined, TorPp-associated PI 4-kinase activity was 1 O- 
fold lower in cells grown at the restrictive temperature, but 
the high level of activity associated with the mutant ToRp 
at the permissive temperature was not temperature sensi- 
tive in vitro (Cardenas and Heitman, 1995). Unfortunately, 
neither study included the critical control of testing a pro- 
tein mutated in one of the conserved kinase motifs. This 
is important, because type II PI 4-kinase is activated by 
nonionic detergents, such as those used in cell lysis, and 
has a tendency to bind nonspecifically to immunoprecipi- 
tated proteins (Whitman et al., 1987). Indeed, in a second 
study of FRAP, the associated PI 4-kinase activity was 
found to be unaffected by mutation of either Asp-2338 or 
Asp-2357, which are, respectively, in motifs I and II in the 
PI 3-kinase domain, indicating that the PI 4-kinase activity 
is associated rather than intrinsic (Brown et al., 1995). It 
is possible that the conditions needed to reveal an intrinsic 
PI kinase activity have not been found, but this suggests 
that the PI 3-kinase domain might have another activity. 
Some PI 3-Kinase Family Members Have Protein 
Kinase Activity 
The first hints that a PI 3-kinase-related protein might have 
protein kinase activity came from a study of the pl 1 O/p85 
complex itself, in which it was shown that ~110 has an 
associated Mn2+-dependent protein kinase activity that 
can phosphorylate a specific serine, Ser-608, in the ~85 
subunit, resulting in inhibition of PI 3-kinase activity (Car- 
penter et al., 1993; Dhand et al., 1994). Mutation of Arg- 
916 in motif I in the PI 3-kinase domain not only eliminates 
PI 3-kinase activity but also abolishes the protein-serine 
kinase activity, establishing that this activity is intrinsic 
(Dhand et al., 1994). This phosphotransfer usually occurs 
within the ~1101~85 heterodimer (Dhand et al., 1994) but 
under some conditions, phosphorylation of exogenous 
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Figure 1. Sequences Conserved between the PI 3-Kinase and Protein 
Kinase Families 
In the protein kinase catalytic domain, subdomain VI forms a loop that 
has been termed the catalytic loop. The asparatic acid (shown in bold) 
in this domain is the proposed catalytic base that hydrogen bonds to 
the hydroxyl group in the acceptor amino acid: the asparagine (shown 
in bold) helps stabilize the catalytic loop through hydrogen bonding. 
Mutation of either residue abolishes catalytic activity. The aspartic 
acid (shown in bold) in subdomain VII also lies in a loop and chelates 
the primary activating Mg- that bridges the p- and r-phosphates of 
ATP and helps position the y-phosphate for transfer. Mutation of this 
residue also abolishes catalytic activity. 
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Table 1. Properties of PI 3-Kinase Family Members 
Protein Function Enzymatic Activity 
plloa, p11op PI 3-kinase associated with regulatory ~85 SH2/SH3 
subunit; involved in signaling by receptor protein- 
tyrosine kinases 
PllOY PI 3-kinase activated by G protein PT subunits 
PI 3-kinase PI 3-kinase homolog of yeast Vps34p 
PI 4-kinase Type II PI 4-kinase 




Response to ionizing radiation DNA damage 
Protein kinase required for V(D)J recombination 
and DSB repair 
Drosophila 





Tori p, TorZp 
PI 3-kinase required for vacuolar protein sorting 
PI 4-kinase 
PI 4-kinase 
Bind rapamycin/FKBPI2; required for sensitivity to 
growth inhibition by rapamycin 
Tell p 
Mecl p (Esrl p) 
Maintenance of telomere length 
DNA damage S and G2 checkpoints; meiotic 
recombination 
S. pombe 
Rad3 DNA damage S and G2 checkpoints; DNA repair 
Phosphorylates 3’ position of PI, Pl(4)P, and Pl(4,5)P2, 
has preference for Pl(4,5)P2; phosphorylates Ser608 
in ~85, decreasing PI 3-kinase activity 
Phosphorylates 3’ position of PI, Pl(4)P, and Pl(4,5)P2 
Phosphotylates 3’ position of PI 
Phosphorylates 4’ position of PI; activated by nonionic 
detergents 
Autophosphorylates on Ser 
Unknown 
Bona fide protein kinase stimulated by double-stranded 
DNA ends: lacks lipid kinase activity 
In some cases the same protein has been identified in independent studies; the alternate names are given in parentheses. The accession numbers 
for the sequences listed in this table are: pl lOa (229090); pl lOl, (567334); ~110~ (X83368); PI 3-kinase; type II PI 4-kinase (L36151); FRAP 
(L34075) (RAFT1 [UllSSl]; RAPT1 [L35478]); ATM (U26455); DNA-PK (U34994); mei- (U34925); Vps34p (X53531); Piklp (X76058); Stt4p 
(D13717); Torlp (X74857); ToRp (X71416); Tell p (U31331); Meclp (U31109) (Esrlp [DllOSS]); Rad3 (X63544). A family of five PI 3-kinase-related 
genes has been identified in Dictyostelium; two are related to ~110, one to Vps34p, and two to PI 4-kinase (Zhou et al., 1995). 
Phosphorylates 3’ position of PI 
Phosphorylates 4’ position of PI 




~85 can be observed (Carpenter et al., 1993). It has also 
been reported that pl lo/p85 can phosphorylate the insulin 
receptor protein-tyrosine kinase substrate IRS-1 in a wort- 
mannin-sensitive manner (Lam et al., 1994). The yeast 
Vps34p, which is involved in vacuolar protein sorting, has 
intrinsic PI 3-kinase activity (Schu et al., 1993), but was 
also found to autophosphorylate on serine, threonine, and 
tyrosine in vitro in a MnZ+-dependent manner in the ab- 
sence of lipid substrate (Stack and Emr, 1994). Both this 
autophosphorylating activity and PI 3-kinase activity are 
lost upon mutation of conserved motif I and II PI 3-kinase 
domain residues. So far, however, Vps34p has not been 
shown to phosphorylate an exogenous protein substrate, 
and autophosphorylation does not affect its PI 3-kinase 
activity. Thus, the significance of the Vps34p autophos- 
phorylating activity remains unclear. 
It has also recently been found that FRAP can autophos- 
phorylate on serine in vitro (Brown et al., 1995). This Mg”- 
dependent activity is abolished by mutation of Asp-2338 
or Asp-2357 in the PI 3-kinase domain and is specifically 
inhibited by rapamycinlFKBP12. However, FRAP has not 
yet been shown to phosphorylate any protein substrate 
other than itself. 
The Double-Stranded DNA-Dependent Protein Kinase 
Is a Member of the PI 3-Kinase Family 
The most compelling evidence that members of this family 
can have protein kinase activity is the recent report that 
the large catalytic subunit of the double-stranded DNA- 
dependent protein kinase (DNA-PK) lacks a conventional 
protein kinase catalytic domain, but has a PI 3-kinase do- 
main (Hartley et al., 1995). DNA-PK behaves as a conven- 
tional protein kinase and can catalyze phosphorylation of 
several proteins in vitro, although physiological substrates 
are not known. DNA-PK is a heterotrimeric enzyme whose 
activity is stimulated by the ends of double-stranded DNA 
molecules and that only phosphorylates substrates effi- 
ciently when they are bound to DNA. The large - 450 kDa 
subunit is proposed to contain the catalytic domain, and 
two smaller subunits, which are collectively known as Ku, 
have DNA-binding activity. Formal evidence is lacking that 
the PI 3-kinase domain of DNA-PK is responsible for its 
protein kinase activity, but this seems a reasonable suppo- 
sition, especially since DNA-PK activity is inhibited by 
wortmannin, a potent inhibitor of pl lo-related PI 3-kinase 
activity, albeit at a relatively high concentration. Highly 
purified DNA-PK lacks detectable lipid kinase activity 
(Hartleyet al., 1995). Therefore, although one could argue 
that the right conditions for lipid phosphorylation have not 
been found, at present it appears that DNA-PK is exclu- 
sively a protein kinase. 
The DNA-PK large subunit gene has recently been 
shown to be the locus mutated in SCID mice, which have 
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a defect in V(D)J recombination in T and B cells (reviewed 
byzakian, 1995). Cells from SCID mice lack DNA-PK activ- 
ity and exhibit double-stranded DNA break (DSB) repair 
defects that can be complemented by a cosmid containing 
the DNA-PK locus. The defects in V(D)J recombination 
and DSB repair are consistent with the fact that DNA-PK 
is normally activated by double-stranded DNA ends. Pre- 
sumably, DNA-PK phosphorylates one or more proteins 
in the DNA-bound recombination and repair complexes, 
but these proteins have not been identified. 
Are other PI 3-kinase family members also protein ki- 
nases? Sequence comparison of PI 3-kinase domains of 
members of this family indicates that there are at least 
three subfamilies, one consisting of ~110 and Vps34p 
(these can be considered distinct based on their specifici- 
ties for different PI species), one containing Torl p/Tor2p 
and FRAP, and the third comprising the DNA damage 
response members of the family (Figure 2). Members of 
all three subfamilies have been shown to have intrinsic 
protein kinase activity, although for the first two subfami- 
lies, this is restricted to autophosphorylating activity. Auto- 
phosphorylation, per se, is not a good indicator of protein 
kinase activity, since many ATP-binding proteins that are 
not protein kinase are known to autophosphorylate in vitro. 
DNA-PK is a genuine protein kinase, but other members 
of the third subfamily have not been tested. At present, 
it is too early to say whether the relationships deduced 
from the PI 3-kinase family tree really reflect differences 
in intrinsic kinase substrate specificity and will allow one 
to predict whether a member is a PI or a protein kinase. 
In the protein kinase superfamily, the percent identity be- 
tween any pair of protein kinases can be as low as 20%, 
a value that is surpassed by all pairwise comparisons of 
DNA-PK, an authentic protein kinase, with other members 
of the PI 3-kinase family. The case that any of these are 
truly protein kinases would obviously be strengthened if 
bona fide substrates could be identified. 
DNA Damage Response and Repair Proteins Are 
Members of the PI 3-Kinase Family 
In addition to DNA-PK, several of the recently described 
members of the PI 3-kinase family have roles in DNA dam- 
age response and repair (reviewed by Zakian, 1995). In 
budding yeast, Tellp and Meclp have partly redundant 
functions involved in sensing genomic integrity. Tellp is 
required to maintain telomere length, but it is not essential, 
and cells lacking Tellp do not show increased sensitivity 
to DNA-damaging agents (Greenwell et al., 1995; Morrow 
et al., 1995). Mecl p, on the other hand, is essential and 
is required for the DNA damage checkpoints in S and G2 
and for meiotic recombination. The sensitivity of cells lack- 
ing Meclp to DNA-damaging agents can be rescued by 
an increased dosage of Tellp, indicating that they have 
related but not identical functions. In Schizosaccharo- 
myces pombe, Fiad3, which is not essential, is also re- 
quired for the S and G2 checkpoints and directly for DNA 
repair (Jimenez et al., 1992). In humans, the inactivation 
of the ataxia telangiectasia gene (ATM) leads to chromo- 
somal abnormalities, increased sensitivity to ionizing radi- 
ation, and loss of DNA damage checkpoint control; the 
loss of DNA-PK leads to defects in DSB repair and V(D)J 
recombination. In Drosophila, mutation of mei- leads to 
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Figure 2. Relatedness Tree of Proteins in the PI 3-Kinase Family 
This figure is based on an analysis using Genetics Computer Group 
software carried out by J. Sekelsky in Hawley’s laboratory at the Univer- 
sity of California, Davis and presents the relatedness of the indicated 
proteins within their C-terminal PI 3-kinase domains. The percent iden- 
tity of the sequence of the PI 3-kinase domain of each protein with 
that of the PI 3-kinase domain in the ATM protein is listed on the right. 
The equivalent domain in the PI 4-kinases is also -30% identical to 
the domain in pi 10 and Vps34p. 
increased sensitivity of ionizing radiation, defects in DSB 
repair, and mitotic and meiotic chromosome instability 
(Hari et al., 1995). Mutation of conserved motif I and II PI 
3-kinase domain residues in Tell p abolishes its ability to 
complement the short telomere phenotype (Greenwell et 
al., 1995), suggesting that the activity of the PI 3-kinase 
domain is essential, but this needs to be established for 
the other proteins. 
There is reasonably good evidence that the stimulation 
of pl 1 O-mediated PI 3-kinase activity plays a critical role in 
signaling pathways activated by receptor and nonreceptor 
protein-tyrosine kinases. Could activation of the PI 3-kinase 
domain and consequent generation of 3’ phosphoinosi- 
tides explain the diverse and specific functions of these 
proteins in DNA damage response and repair? The ef- 
fector proteins for 3’ phosphoinositides are not known, 
although there are reports that one or more protein kinase 
C isoforms and the Akt protein-serine kinases can be acti- 
vated by 3’ phosphoinositides in vitro. Nevertheless, de- 
spite the lack of knowledge about downstream effecters 
for the PI 3-kinases, there is no reason to believe that 3’ 
phosphoinositides will behave any differently from other 
second messengers, which have no intrinsic specificity. 
Such a system would not seem to be the one of choice 
for providing specific responses to different types of DNA 
damage, because the common second messenger would 
activate a common set of effecters, thus precluding the 
necessary response specificity. Moreover, the majority of 
chromosomal DNA is not intimately associated with phos- 
pholipids in the nucleus, and, although there is a nuclear 
PI cycle, if these PI 3-kinase family members are directly 
associated with damaged DNA when activated, like DNA- 
PK, it is not clear how easily they would gain access to 
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substrate PI molecules in the inner nuclear membrane. 
Teleologically, it would make more sense if these proteins 
were indeed protein kinases, which display a high degree 
of specificity for their substrates, and could readily provide 
the necessary response specificity to different types of 
DNA damage. In this regard, one reason for the unusually 
large size of most of these proteins may be that they not 
only contain domains necessary for association with other 
proteins or DNA (or both) in repair or recombination com- 
plexes but also domains for association with protein sub- 
strates that are then phosphorylated by the PI 3-kinase 
domain. 
One cautionary note emerges from the finding that some 
members of the PI 3-kinase family are protein kinases. 
Wortmannin and LY294002 are commonly used as sup- 
posedly specific inhibitors of PI 3-kinase activity (Ui et al., 
1995). However, wortmannin also inhibits the protein ki- 
nase activity of DNA-PK, and even though the lG0 for 
inhibition of DNA-PK is nearly two orders of magnitude 
higher than that for inhibition of pl 1 O/p85 PI 3-kinase activ- 
ity and even though not all family members are inhibited 
by wortmannin (e.g., FRAP), it is possible that there are 
protein kinase members of this family that are inhibited 
by wortmannin with lower ICsOs. For instance, the ability 
of wortmannin to inhibit 70K S8K activation by the platelet- 
derived growth factor receptor has been used in conjunc- 
tion with other indirect evidence to conclude that PI 3-ki- 
nase is required for 70K S6 kinase activation. This may 
be the case, but it is not inconceivable that the true target 
for wortmannin is a protein kinase in the PI 3-kinase family 
that lies upstream of 70K S6 kinase, which is activated 
by phosphorylation by an unknown protein kinase(s). 
Conclusions 
We are left with a number of unresolved issues. Some 
members of this family, such as ~110 and Vps34p, appear 
to be bona fide PI kinases; deregulation of these proteins 
causes increased PI phosphorylation in the intact cell. The 
fact that ~110 and Vps34p can also autophosphorylate 
may reflect a specialized autoregulatory mechanism 
rather than a genuine protein kinase function. However, 
at least one member of the family is a bona fide protein 
kinase, and several others may also be protein kinases. 
What dictates which substrate is phosphorylated by a 
member of this family, and do any members of the family 
possess dual lipid and protein kinase specificity? This 
brings us back to the original conceptual problem with the 
idea that v-Src had both protein and lipid kinase activity, 
namely, the difficultly in imagining how one .active site 
could be designed to accommodate and phosphorylate a 
hydroxyl on an inositol ring linked to a phospholipid as 
well as a hydroxyl on a serine or threonine in a peptide 
backbone. The PI 3-kinase domain has limited similarity 
to the protein kinase catalytic domain, possessing only 
two motifs known to be involved in phosphotransfer. Thus, 
it is not surprising that mutation of conserved residues in 
these motifs abolishes kinase activity toward both types 
of substrate. Extensive mutational analysis is needed to 
determine whether the peptide- and lipid-binding sites are 
overlapping. It is possible that the sites are separate, and 
one could even lie outside the PI 3-kinase domain. Indeed, 
Meclp, Tellp, Rad3, ATM, and mei- all have a large 
related domain upstream of the PI 3-kinase domain that 
seems likely to be functionally important, and the Tori 
FRAP family have several related domains in addition to 
the PI 3-kinase domain, one of which is involved in rapa- 
mycinlFKBP12 binding (see Figure 2 in Hari et al., 1995). 
Targeting subunits may also play a role in substrate selec- 
tion, as is the case for DNA-PK. Finally, does the relation- 
ship between the PI 3-kinase and the protein kinase fami- 
lies represent a divergent evolutionary origin, and, if so, 
did this domain originally function as a lipid kinase or a 
protein kinase? 
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